chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a female who on 25-AUG-2008 morning was vaccinated intramuscularly with her second dose of GARDASIL. (Dose, site of administration and lot number not reported). Couple hours later the patient called the office back and said she had pulsating in her right eye and was unable to focus. The patient went to the emergency room and was still there. The outcome of the patient was known. Additional information has been requested.
10FEB93 MN temp 106 R; APAP/baths would take it down then go back up to 106 R; lasted for 3 days on 11FEB93; broke out in pinpoint rash all over body; changed to dime size welts;
Throat tightened, became hard to swallow. Chest tightness, and became dizzy. First symptom to occur was the throat; felt as if a rock was stuck. Chest tightness followed and dizziness after. All symptoms occurred after the 15 minute waiting period; EMS was called and I took a Benadryl to immediately combat the symptoms.
REDNESS; itchiness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (REDNESS) and PRURITUS (itchiness) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Cholesterol.    On 08-Mar-2021 at 8:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced ERYTHEMA (REDNESS) and PRURITUS (itchiness). On 13-Mar-2021, PRURITUS (itchiness) had resolved. At the time of the report, ERYTHEMA (REDNESS) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product included blood pressure and cholesterol medication. Treatment information included hydrocortisone cream.
In less than 24 hrs. after injection, experienced pain in the injection site, fever with chills, fatigue, muscle/joint pain and headache.
Headache, Arthralgia, Diarrhea, Fatigue, neck pain left side posterior, injection site soreness Narrative:
I have a rash on the injection site as well as under my arm pit. I also felt like I had the flu because I was sore woke up sore the night of the first shot feeling like I had body aches and couldn?t get comfortable for the rest of the night. I was also very lethargic the next day very tired and nauseous as soon as I got up in the morning and had to go to the restroom because I had diarrhea that morning. I still have soreness and a slight rash on my left arm near the injection site but it is resolving itself and I have not had any issues with aches and pains as I?ve been taking ibuprofen sense the first night but not as I don?t need it as much so things seem to be improving.
She had a high fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (She had a high fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced PYREXIA (She had a high fever). At the time of the report, PYREXIA (She had a high fever) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.
This is a spontaneous report from a contactable nurse. A 12-month-old female patient received the fourth dose of PREVNAR 7 intravenously on an unspecified site of administration 05Sep2007. The patient previously received the first, second and third doses of PREVNAR 7 on 28Nov2006, 27Mar2007 and 01Jun2007. Relevant medical history was unknown. Relevant concomitant medications were unknown. Vaccines given on the same day were unknown. Past vaccine history included DTaP and HIB on 02Feb2007. On an unspecified date, at the age of 5 years, the patient was diagnosed with no immunity to Streptococcus pneumonia. The patient underwent an immunoglobin G (IgG) test for Streptococcus pneumonia on an unknown date which revealed no immunity to Streptococcus pneumonia. The event did not require an emergency room or doctor visit. At the time of the report, the outcome of the event was unknown. Follow-up (21Oct2011): Follow-up attempts completed. No further information expected.
herpes zoster; This initial spontaneous report was received from a lawyer regarding case in litigation and refers to a female patient of unspecified age. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On or about 11-SEP-2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, frequency, route of administration, anatomical location, lot number and expiration date were not provided) for the long-term prevention of shingles and zoster-related conditions.  Subsequent to patients inoculation, patient was treated by a healthcare provider for herpes zoster. As a direct and proximate result of the patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. At the time of the report, the outcome of shingles was considered as not recovered.  The reporter considered herpes zoster to be related to Zoster Vaccine Live (ZOSTAVAX).
MD notified, no harm to pt; pt did not need this vaccine, MA gave wrong vaccine.
Infant very fussy crying constantly for 2 days since she was given the Rotateq. Infant had no symptom prior to that. No fever/decreased feedings.
Hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced URTICARIA (Hives). The patient was treated with DIPHENHYDRAMINE at a dose of 50 milligram. At the time of the report, URTICARIA (Hives) was resolving.            Concomitantly, patient was taking blood thinner and antidepressant medications.
I had cold like symptoms.  I had a runny nose and sneezing. I was coughing and tired.  I also had a headache.  I was coughing up yellow stuff.  These symptoms lasted about 4 days, but I still have the cough.  I did a rapid Covid-19 test it was negative.  I then went to urgent care, and they did another Covid-19 test, which came back positive. On Dec 22nd, I did another Covid-19 test, still positive results.
Initially he had symptoms of pre-syncope, light-headed, sounds muffled, and then headache, not feeling well, light sensitivity, and fever developed.  Continues to have symptoms today.  No treatment at this time.
Evening of 02/04/2004 around 16:00 noticed pinpoint starting on lower leap and now on arm and trunk-Erythematous rash.  Joints are very achy including wrists, ankles, fingers.
No adverse event; Received a vaccine that underwent a temperature excursion; Received a vaccine that underwent a temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Received a vaccine that underwent a temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Received a vaccine that underwent a temperature excursion) and NO ADVERSE EVENT (No adverse event) in a 9-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. AS1412B and AS1414B) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jul-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Aug-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Received a vaccine that underwent a temperature excursion). On 13-Aug-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Received a vaccine that underwent a temperature excursion). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Received a vaccine that underwent a temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Received a vaccine that underwent a temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Received a vaccine that underwent a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Received a vaccine that underwent a temperature excursion).    The patient had a weight of 20 (unit not specified). No concomitant medication was reported by reporter. The patient had Moderna administration location on LQ (unspecified).  Some vaccines were stored in the freezer and other vials in the refrigerator. The excursion occurred on 7-Aug-2022 and was picked up by state review of the temperature data logger 2 weeks later after the excursion. Total 38 patients received this.  1 refrigerated vial was with lot number AS1412B and expiration date 10-Feb-2023. Maximum or minimum temperatures reached was 14 degrees Celsius for 3hr 5min. Vial was moved from refrigerator on 8-Aug-2022. Those were administered or discarded. Proposed desired used by date was 18-Aug-2022. No treatment medication was reported by reporter.
Vision problems primarily in the right eye. Still on going. Was hospitalized. Diagnosed with Optic Neuritis
Pt came in from playground feeling bad; temp 102 orally, rapid pulse & was sweating; Laid pt down & had a sz lasting approx 30 sec in duration; Taken to MD;
This is per school nurse. Pt had seizure while in class after receiving H1N1. Pt has history of seizures. Was taken out of class. Parents call and went to hospital. Was discharged in parents care.
30 minutes after receiving the shot I became dizzy, head hurt, burning eyes, fatigue and nauseous. The second day to present day, all the symptoms from first day plus a stomachache.  Over the course of the next week, all symptoms continued then chest pains and a high resting pulse began. Eight days after the shot I went to the emergency room for chest pains and all the symptoms from above. I followed up with primary care three days after ER visit and was told of a possible pancreatitis. My gastroenterologist does not have time in his schedule to see me anytime soon. I?m in the process of trying to get an appointment with a gastroenterologist. If symptoms worsen I will go back to emergency room.  I?m waiting to be accepted by a office for treatment.
Vaccine given 2 days out of date beyond use date. Patient does not report any unusual signs and symptoms or local reactions.
seizure lasting 5 to 10 minutes, with legs and arms jerking and complete loss of consciousness.
On 11/8/02, at 16:05, client contacted me and gave me a verbal report of the signs and symptoms she experienced after she received the Influenza vaccination on 11/4/02. The client reported the following: itching, hives, swollen tongue and blisters on lips and tongue which started on 11/5/02 and lasted until 11/8/02. She stated that she also had some difficulty breathing. On 11/8/02, went to ER because of increased difficulty breathing. Dx'd as an allergic reaction and they gave her "a shot" and 2 pills, and also a prescription for Benadryl 50mg po q 6 hrs. On 11/8/02, she stated "I am doing better, no hives, no fever, my tongue is decreased by 75% and my swallowing and breathing is better".
The pt came to the office 8/1/01 with onset of episodic repetitive eye deviation to the right which developed the day after her immunizations. Parents had videotaped these-they had the appearance of seizures. She was hospitalized 8/4/01-8/7/01 and diagnosed with infantile spasm. This was terated with a couple months of injectable ACTH. SEizures recurred 12/01 but not since a 2nd course of ACTH. However, she has a significant development delay following the development of infantile spasm. Follow up report states " Significant developmental delay (both motor skills & speech).Pt is still working with PT/OT to help her strethen leg muscles to learn to stand.Just learned how to sit;just starting to armycrawl with arms.she doesn't make more than 1-2 sounds.Still workingon correctly swallowing solid foods. All of these residual symptoms are a result of the developmental regression (and now delay) following the onset of infantile spasms, a rare seizure disorder, which started the day following receipt of immunizations. Follow up on 11/05/2003: "Vaccine recipient did not recover from the adverse event.  The patient developed infantile spasm (seizure disorder).  Associated with encephalopathy and developmental regression.  She has been seizure free now for over 1.5 year but at age 2.5, she has gross motor skills of a 10-11 month old and speech of a 4-6 month old.  She does continue to make progress."  Nurse follow up on 06/30/04 states: "No new information."
Pt developed circumoral paresthesia (tingling of her lips and tongue) shortly after injection into right deltoid without shortness of breath, chest pain, rash, sore throat, hives, myalgias, nausea, or vision changes. She reports feeling anxious regarding the crowded atrium while getting her shot.  Patient symptoms improved after monitoring for 30 minutes with stable vital signs without administration of medications.
Fever, ErythemaMultiform, NauseaVomiting, fatigue, fever, nausea, arm soreness Narrative:  Extreme fatigue, fever, nausea, arm soreness; recovered by 1/15/21.
Pt recv vax on 2/19/99; on 3/2/99 pt exp decreased PT
3 days later had swollen lymph nodes and my joints hurt, ankles, knees, back and a general malaise feeling 6 days later red itchy lump at injection site on right arm got progressively worse over the next 25 hours .. hot to touch, slightly painful lump and very itchy in that area
Per md's note, on Friday pm pt had emesis in the afternoon. Next day, large red hot swollen area over arm tried cold compress. Painful, gave Motrin for tactile temp.
23MAY91 PT recd vax (1cc, IM, deltoid); 8JUN91 PT exp fever (t104.2 ax), chills, flu-like pain in joints, polyarthralgia, but no erythema or edema; PT had t102-103 @ home, but normal temp 10JUN91; seen in ER 10JUN91; rx: Vibra-Tabs & Advil
received both doses of the vaccine and is pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (received both doses of the vaccine and is pregnant) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Hypercholesteremia.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 07-Oct-2020 and the estimated date of delivery was 14-Jul-2021. On 07-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (received both doses of the vaccine and is pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirteenth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (received both doses of the vaccine and is pregnant) had resolved. Not Provided          Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Patient details are updated
INJECTION SITE REACTION, BODY ACHE, FLU LIKE SYMPTOMS, SICK TO STOMACH.
Seven days post vax, the pt developed an injection site reaction characterized by a welt with itching and pain. The pt recovered.
Patient received Prevnar 20 twice within a 5 month period. Patient reports no adverse reactions.
COVID-19 TEST POSITIVE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced covid-19 test positive. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid-19 test positive was not reported. This report was non-serious.
Narrative:  COVID infection following COVID vaccine series 01/06, Pfizer, dose #1 01/28, Pfizer, dose #2 09/01 pt cc: fatigue exposure: unknown 09/07 ABG: i-pH 7.42, i-PCO2 43.1, i-P02 91, i-HCO3 27.7 09/07 PROCALCITONIN: <0.05 09/07 FERRITIN: 109.2 09/07 FIBRINOGEN: 230 09/07 DDIMER: <0.22 09/07 BNP: 29.3 09/07 TROPONINI: <0.016 09/07 COVID swab, result: detected 09/07 SARS-COV-2 Variant Sequencing result: pending 09/07 CTA PE Impression: No pulmonary embolism. Mild improvement in the chronic bronchiolitis/central airway inflammatory changes in both lungs, mostly notably in the lingula where 7 mm dominant nodule is unchanged. No new alveolar consolidation to favor Covid pneumonia. No pleural effusion. Mild tracheal secretions. 09/07 CXR impression: COPD. No acute pulmonary finding. 09/07 pt admit to ED cc: cough, weakness dx: COVID-19 LOS: 1 DAY
Fever; Chills; Vomiting; Pounding headache; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced fever (Verbatim: Fever), chills (Verbatim: Chills), vomiting (Verbatim: Vomiting) and pounding in head (Verbatim: Pounding headache).  The outcome of the fever, chills, vomiting and pounding in head were resolved (duration 2 days).   It was unknown if the reporter considered the fever, chills, vomiting and pounding in head to be related to Shingles vaccine.   It was unknown if the company considered the fever, chills, vomiting and pounding in head to be related to Shingles vaccine.   Linked case(s) involving the same patient:  US2023AMR130616   Additional Information: GSK Receipt Date: 18-SEP-2023 The case was received from the patient via interactive digital media. The patient stated he/she was vaccinated with shngles vaccine and was scared of shingles. The patient also stated vaccine was no picnic either, but at least was for only two days not months. The patient experienced fever, chills, vomiting and pounding headaches with both doses. This case is linked with US2023AMR130616, 2nd dose. The follow-up would not required per process.; Sender's Comments:  US-GSK-US2023AMR130616:For second dose
rt arm has red, swollen area 1 1/2 x 1 1/2" extremely tender to touch, has muscle aches all over esp legs & lower back;has had a severe h/a since onset of sx, nauseated but better 23OCT97;fever now 23OCT97 102;24OCT97 feeling much better;
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old male patient received BNT162b2 (BNT162B2 NOS), on 10Nov2022 at 16:00 as dose number unknown, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Heart stent" (not ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient received treatment with Paxlovid from 09Mar2023 till 13Mar2023. Patient had no known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300116496 same reporter/patient, different product/AE;
Moderna COVID-19 Vaccine EUA Fever by 10:30pm (100.7) on first day, chills, body aches, nausea  Same symptoms minus fever on second day  Body aches, nausea, severe headache today
Patient received a dose of vaccine that may be less than completely effective due to storage conditions.   No adverse effect noted.
Vertigo; relieved by Epley maneuver. Subsequent hearing deficits both ears for ~ 1 week (ongoing)
Exhaustion, labored breathing, headache, dehydration, body aches, muscle fatigue, sinus congestion, diarrhea, loss of appetite.  Exhaustion: continuing. Remaining symptoms: 2 weeks.
Freezing at one point and burning at one point; Swelling in hand; Muscle cramps; Nausea; Headache not going away; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (Freezing at one point and burning at one point), PERIPHERAL SWELLING (Swelling in hand), MUSCLE SPASMS (Muscle cramps), NAUSEA (Nausea) and HEADACHE (Headache not going away) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (Freezing at one point and burning at one point), PERIPHERAL SWELLING (Swelling in hand), MUSCLE SPASMS (Muscle cramps), NAUSEA (Nausea) and HEADACHE (Headache not going away). At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (Freezing at one point and burning at one point), PERIPHERAL SWELLING (Swelling in hand), MUSCLE SPASMS (Muscle cramps), NAUSEA (Nausea) and HEADACHE (Headache not going away) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant products were not reported by the reporter. Treatment details were not included.